Advanced search
Publication Cover
Expert Review of Clinical Immunology Volume 19, 2023 - Issue 8: Chronic rhinosinusitis
Submit an article Journal homepage
1,829
Views
0
CrossRef citations to date
0
Altmetric
Editorial

What place will tezepelumab hold in the treatment paradigm in chronic rhinosinusitis?

Valentin Faviera Department of ENT Surgery, Gui de Chauliac Hospital, Montpellier University Medical Center, Montpellier, FranceORCID Iconhttps://orcid.org/0000-0002-7999-951XView further author information
ORCID Icon,
Jérémy Charriotb Department of Respiratory Diseases, Univ Montpellier, CHU Montpellier, Montpellier, France;c PhyMedExp, Univ Montpellier, CNRS, INSERM, CHU Montpellier, Montpellier, FranceORCID Iconhttps://orcid.org/0000-0002-1420-5774View further author information
ORCID Icon,
Louis Crampettea Department of ENT Surgery, Gui de Chauliac Hospital, Montpellier University Medical Center, Montpellier, FranceView further author information
,
Arnaud Bourdinb Department of Respiratory Diseases, Univ Montpellier, CHU Montpellier, Montpellier, France;c PhyMedExp, Univ Montpellier, CNRS, INSERM, CHU Montpellier, Montpellier, FranceCorrespondence[email protected]
View further author information
&
Engi Ahmedb Department of Respiratory Diseases, Univ Montpellier, CHU Montpellier, Montpellier, France;c PhyMedExp, Univ Montpellier, CNRS, INSERM, CHU Montpellier, Montpellier, France;d Laboratory of Immunoregulation and Mucosal Immunology, VIB-UGent Center for Inflammation Research, Ghent, BelgiumView further author information
Pages 821-825 | Received 28 Feb 2023, Accepted 16 May 2023, Published online: 21 May 2023

References

  • Passalacqua G, Ciprandi G, Canonica GW. United airways disease: therapeutic aspects. Thorax. 2000;55(2):S26–27.
  • Laidlaw TM, Mullol J, Woessner KM, et al. Chronic rhinosinusitis with nasal polyps and asthma. J Allergy Clin Immunol Pract. 2021;9(3):1133–1141. DOI:10.1016/j.jaip.2020.09.063
  • Chen W, Bai Y, Kong W, et al. Predictive significance of Charcot-Leyden crystal structures for nasal polyp recurrence. Clin Transl Allergy. 2022;12(11):e12212. DOI:10.1002/clt2.12212
  • Nagarkar DR, Poposki JA, Tan BK, et al. Thymic stromal lymphopoietin activity is increased in nasal polyps of patients with chronic rhinosinusitis. J Allergy Clin Immunol. 2013;132(3):593–600.e12. DOI:10.1016/j.jaci.2013.04.005
  • Ordovas-Montanes J, Dwyer DF, Nyquist SK, et al. Allergic inflammatory memory in human respiratory epithelial progenitor cells. Nature. 2018;560:649–654.
  • Feltenmark S, Gautam N, Brunnström A, et al. Eoxins are proinflammatory arachidonic acid metabolites produced via the 15-lipoxygenase-1 pathway in human eosinophils and mast cells. Proc Natl Acad Sci U S A. 2008;105(2):680–685. DOI:10.1073/pnas.0710127105
  • Kristjansson RP, Benonisdottir S, Davidsson OB, et al. A loss-of-function variant in ALOX15 protects against nasal polyps and chronic rhinosinusitis. Nat Genet. 2019;51(2):267–276. DOI:10.1038/s41588-018-0314-6
  • Nocera AL, Mueller SK, Workman AD, et al. Cystatin SN is a potent upstream initiator of epithelial-derived type 2 inflammation in chronic rhinosinusitis. J Allergy Clin Immunol. 2022;150(4):872–881. DOI:10.1016/j.jaci.2022.04.034
  • Bleier BS. Regional expression of epithelial MDR1/P-glycoprotein in chronic rhinosinusitis with and without nasal polyposis. Int Forum Allergy Rhinol. 2012;2(2):122–125.
  • Oykhman P, Paramo FA, Bousquet J, et al. Comparative efficacy and safety of monoclonal antibodies and aspirin desensitization for chronic rhinosinusitis with nasal polyposis: a systematic review and network meta-analysis. J Allergy Clin Immunol. 2022;149(4):1286–1295. DOI:10.1016/j.jaci.2021.09.009
  • Menzies-Gow A, Corren J, Bourdin A, et al. Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma. N Engl J Med. 2021;384(19):1800–1809. DOI:10.1056/NEJMoa2034975.
  • Diver S, Khalfaoui L, Emson C, et al. Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial. Lancet Respir Med. 2021;0(11):1299–1312. DOI:10.1016/S2213-2600(21)00226-5
  • Corren J, Parnes JR, Wang L, et al. Tezepelumab in Adults with Uncontrolled Asthma. N Engl J Med. 2017;377:936–946.
  • Corren J, Larson D, Altman MC, et al. Effects of combination treatment with tezepelumab and allergen immunotherapy on nasal responses to allergen: a randomized controlled trial. J Allergy Clin Immunol. 2023;151:192–201.
  • Menzies-Gow A, Corren J, Israel E, et al. Tezepelumab efficacy in patients with severe, uncontrolled asthma and comorbid nasal polyps in NAVIGATOR. Eur Respir J. 2021;PA876. DOI:10.1183/13993003.congress-2021.PA876.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.